Is kefir good for gut health?

For a few specific gut problems it may help a little, and most of the strong evidence is about fermented milks as a group rather than kefir. A 2024 meta-analysis of 16 randomized trials in 1,264 people with irritable bowel syndrome found that fermented milk raised the chance of symptom relief, a risk ratio of 1.19 with an interval from 1.01 to 1.39. Pain and bloating scores did not fall. The review gives no estimate for kefir alone, and nobody has pooled kefir trials on their own. The kefir trials we found enrolled between 15 and 125 people.

Unsettled. Kefir has a few small positive trials and one null one, and each tests a different thing in different people. The general promise on the bottle, a healthier gut for a healthy person, rests for kefir itself on one trial in 65 young adults that reported fewer gut symptoms without saying how many fewer. Changes in gut bacteria are real and modest, and whether they do anything for health has not been shown.

What the trials found

Fermented foods and fermented milks as a group

A 2025 meta-analysis pooled 19 randomized trials of fermented foods in healthy adults, from 25 studies covering 4,328 people. Bowel movements became slightly more frequent, a mean difference of 0.60 with an interval from 0.04 to 1.16, and the abstract does not say per day or per week. Stools came out 0.25 points softer on the Bristol stool scale, and gut symptoms fell by a standardized difference of 0.60. Heterogeneity between trials was high, the authors graded the certainty mostly low, and the abstract does not say how many of the trials used kefir.

In people with irritable bowel syndrome, all fermented foods together raised symptom relief with a risk ratio of 1.22 across 12 trials in 975 patients. Fermented milks with added probiotic strains make up most of that evidence, and the abstract reports no absolute rates, so we cannot say how many more people out of 100 felt better.

Established. Added to antibiotic treatment for H. pylori, fermented milk raises the chance of clearing the infection. A 2009 meta-analysis of 10 trials in 963 people put the gain at about 10 more people cured out of every 100, with an interval from 5 to 15, and an odds ratio of 1.91. Most of those drinks were yogurt-type probiotic milks rather than kefir, some trials were only quasi-randomized, and the milk was an add-on to the antibiotics, never a treatment on its own.

Kefir itself

H. pylori. In one double-blind trial in Bursa, Turkey, 82 people with dyspepsia took 14 days of triple therapy with either 8.5 fl oz (250 mL) of kefir twice a day or placebo milk. The infection cleared in 36 of 46 on kefir (78.2 percent) against 18 of 36 on placebo (50.0 percent), and side effects were less frequent. It was a single center with unequal arms, and we read only the abstract.

Lactose. In 15 adults with lactose maldigestion in Ohio, a single test meal with 20 g of lactose in plain kefir produced a breath hydrogen area of 87 against 224 with 2 percent milk. Flavored kefir came in between, at 156. The yogurts and kefirs tested cut the severity of flatulence by 54 to 71 percent against milk. That is one meal in 15 people.

Antibiotic diarrhea in children. In 125 children aged 1 to 5 on antibiotics, a daily commercial kefir did not prevent diarrhea: 18 percent had it on kefir and 21.9 percent on a heat-killed kefir placebo. The trial was too small to detect a modest effect, so this is an open question rather than a closed one.

Healthy young adults. In 65 healthy young adults in Turkey, 8.5 fl oz (250 mL) of lactose-free kefir a day for 6 weeks lowered gut symptoms (P below 0.05). The abstract gives no size for that change, and immune and inflammation markers did not move.

Inflammatory bowel disease. In an open-label trial of 45 people with ulcerative colitis or Crohn's disease, 14 fl oz (400 mL) of kefir a day for 4 weeks raised fecal Lactobacillus. In the Crohn's group bloating fell (p = 0.012) and CRP fell. Nobody was blinded, and disease activity was not reported.

Constipation. In 20 people with chronic constipation, 17 fl oz (500 mL) of kefir a day for 4 weeks increased stool frequency and cut laxative use (p = 0.031). There was no control group, so placebo and natural improvement cannot be ruled out, and the authors themselves call for controlled trials.

The gut bacteria

In a crossover trial of 26 healthy adults, 8 oz a day of dairy fermented with kefir cultures for 4 weeks raised fecal Lactobacillus by 235 percent against a non-fermented control drink. The trial measured no symptoms. A 2026 systematic review found only 8 human studies of kefir and the gut microbiome, out of 2,743 records screened. The shifts were modest and mixed, Bifidobacterium rose in 3 of 4 studies that measured it, and the review did not show that any of it changes health.

Who should be careful

Not for everyone. Kefir is a milk drink, so milk allergy rules it out. The one study built to test the safety of live kefir gave up to 8.1 fl oz (240 mL) a day to 54 critically ill adults and found no bloodstream infections, fungal infections or deaths linked to it, with a median exposure of only 3 days and no control group. That study excluded people on immunosuppressants for a month or more, including corticosteroids from 10 mg a day, TNF-alpha inhibitors and monoclonal antibodies. It also excluded people with a damaged bowel, dairy intolerance or milk allergy, and pregnant women. Its reassurance does not reach those groups.

For people who digest lactose poorly, the small test-meal trial above suggests plain kefir causes less gas than the same lactose in milk. In the ICU study, the 2 patients who had diarrhea were also on laxatives and tube feeds.

What expert bodies say

The EU register of health claims has no claim that names kefir. The nearest authorized claim says live cultures in yogurt or fermented milk improve the digestion of the lactose in that product, in people who have difficulty digesting lactose. To use it, a product must contain at least 100 million live Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus per gram. Traditional kefir grains carry other bacteria and yeasts, so most kefirs do not meet that wording. A search of the US federal health claim rules for kefir returned nothing.

How we searched

What would change this answer

• A meta-analysis of kefir trials alone, for any gut outcome. None exists, so every pooled number on this page is borrowed from fermented milks as a group.
• A placebo-controlled trial of kefir in constipation. The only kefir data are an uncontrolled pilot in 20 people.
• A second, larger trial of kefir alongside H. pylori treatment, with equal arms and a reported interval. One trial of 82 people is a promising result, not a settled one.
• Safety data in people on immunosuppressants and in pregnancy, the groups the one safety study left out. The registry search found no trial beyond that completed ICU study.

More on kefir as a food, including what a cup contains, is on the kefir page.

Sources

1. ev-kefg-01 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs, GRADE · n = 4,328
   Certainty of evidence was highly variable and mostly low.
   
   Who: healthy adults in 25 studies, 19 randomized controlled trials in the meta-analysis
   Effect: bowel movement frequency MD 0.60 (95% CI 0.04 to 1.16, I2 74%); Bristol stool form MD 0.25 (0.03 to 0.47); GI symptoms SMD -0.60 (-1.05 to -0.15, I2 90%); transit time -13.65 (-21.88 to -5.43)
   Certainty: Class-level evidence: fermented foods in general, kefir share not reported in the abstract; high heterogeneity (I2 72-95%); authors grade certainty mostly low. Time unit of the frequency outcome not stated in the abstract.
   Front Nutr, 2025 · checked 2026-10-06 · we read the abstract
2. ev-kefg-02 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs, PROSPERO CRD42024576608 · n = 1,264
   Subgroup analysis showed that fermented milk had a beneficial effect on symptom relief (RR 1.19, 95% CI 1.01 to 1.39, p = 0.04, I 2 = 0%).
   
   Who: patients with irritable bowel syndrome in 16 randomized controlled trials
   Effect: symptom relief, all fermented foods RR 1.22 (95% CI 1.04 to 1.42, I2 0%, 12 RCTs, 975 patients); fermented milk subgroup RR 1.19 (1.01 to 1.39); no significant change in abdominal pain or bloating scores
   Certainty: Fermented milks with added probiotic strains dominate; no kefir-only estimate. Authors ask for caution given evidence limits.
   Front Nutr, 2024 · checked 2026-10-06 · we read the abstract
3. ev-kefg-03 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized controlled trials · n = 963
   Fermented milk-based probiotic preparations improve H. pylori eradication rates by approximately 5-15%, whereas the effect on adverse effects is heterogeneous.
   
   Who: patients infected with Helicobacter pylori, adults and children, 10 randomized or quasi-randomized trials
   Effect: eradication OR 1.91 (95% CI 1.38 to 2.67, 9 studies, ITT, fixed effects); risk difference 0.10 (0.05 to 0.15); adverse effects OR 0.51 (0.10 to 2.57), heterogeneous
   Certainty: 2009, fermented milks in general (mostly yogurt-type probiotic drinks), kefir not separated; quasi-randomized trials allowed. Adjunct to antibiotics, not a treatment on its own.
   Eur J Gastroenterol Hepatol, 2009 · checked 2026-10-06 · we read the abstract
4. ev-kefg-04 · Randomized controlled trial(s) · systematic review of human interventional studies, no pooling · n = 8 studies
   Kefir consumption was associated with modest and heterogenous changes in gut microbiota composition.
   
   Who: 8 human interventional studies selected from 2,743 records
   Effect: minor changes at phylum and class level; Bifidobacterium increased in 3 of 4 studies; kefir strains found in feces
   Certainty: Not level A: no meta-analysis and non-randomized studies included (risk of bias assessed with a non-randomized tool as well).
   Microbiologyopen, 2026 · checked 2026-10-06 · we read the abstract
5. ev-kefg-05 · Randomized controlled trial(s) · randomized double-blind placebo-controlled trial, 14 days, test at day 45 · n = 82
   Significantly more triple therapy + kefir patients achieved eradication (36 of 46 [78.2%]) compared with triple therapy + placebo patients (18 of 36 [50.0%]) (P = .026, χ(2) test).
   
   Who: consecutive patients with dyspepsia and H. pylori confirmed by urea breath test, Bursa, Turkey
   Effect: eradication 36 of 46 (78.2%) with kefir vs 18 of 36 (50.0%) with placebo milk, P = .026; side effects less frequent and less severe
   Certainty: Single center, unequal arms (46 vs 36), no CI reported in the abstract; adjunct to antibiotics only.
   Journal of Medicinal Food, 2011, 14(4):344-347 (Bekar et al.) · checked 2026-10-06 · we read the abstract
6. ev-kefg-06 · Randomized controlled trial(s) · randomized block design, single test meals of 20 g lactose · n = 15
   The yogurts and kefirs all similarly reduced the perceived severity of flatulence by 54% to 71% relative to milk.
   
   Who: healthy free-living adults with lactose maldigestion, Ohio, USA
   Effect: breath hydrogen AUC 87 ppm x h with plain kefir vs 224 with 2% milk (P<.001); flavored kefir 156 (intermediate); flatulence severity down 54% to 71% vs milk
   Certainty: Single-meal test, small sample; flavored kefir worked less well.
   Journal of the American Dietetic Association, 2003, 103(5):582-587 (Hertzler and Clancy) · checked 2026-10-06 · we read the abstract
7. ev-kefg-07 · Randomized controlled trial(s) · double-blind randomized placebo-controlled trial (heat-killed kefir placebo) · n = 125
   In our trial, kefir did not prevent AAD.
   
   Who: children aged 1 to 5 years in primary care, Washington DC area, receiving antibiotics
   Effect: diarrhea over 14 days 18% vs 21.9%, RR 0.82 (95% CI 0.54 to 1.43); no difference in secondary outcomes
   Certainty: Commercial kefir; underpowered for a small effect.
   Arch Pediatr Adolesc Med, 2009 · checked 2026-10-06 · we read the abstract
8. ev-kefg-08 · Randomized controlled trial(s) · randomized controlled trial, 6 weeks, NCT06612164 · n = 65
   The results revealed a significant decrease in gastrointestinal symptoms, along with reduced serum cholesterol, creatinine, and uric acid concentrations, after kefir intervention (P < 0.05).
   
   Who: healthy young adults, Turkey
   Effect: significant decrease in gastrointestinal symptoms after 6 weeks (P < 0.05); immunity and inflammation markers unchanged
   Certainty: Small, unblinded control likely; symptom size not given in the abstract.
   J Nutr, 2026 · checked 2026-10-06 · we read the abstract
9. ev-kefg-09 · Randomized controlled trial(s) · single-center prospective open-label randomized controlled trial, 4 weeks · n = 45
   According to our data, kefir consumption may modulate gut microbiota, and regular consumption of kefir may improve the patient's quality of life in the short term.
   
   Who: patients with ulcerative colitis or Crohn's disease, single center, Turkey
   Effect: fecal Lactobacillus load up (p=0.001 UC, p=0.005 CD); in Crohn's disease bloating down (p=0.012), ESR and CRP down, feeling-good scores up (p=0.032)
   Certainty: Open label, 25 vs 20, short; disease activity outcomes not reported.
   Turk J Gastroenterol, 2019 · checked 2026-10-06 · we read the abstract
10. ev-kefg-10 · Randomized controlled trial(s) · single-blind randomized controlled crossover trial, 4 weeks per arm, NCT02849275 · n = 26
    Lactobacillus was increased by 235% following fermented dairy consumption compared to the control (p < .01).
    
    Who: healthy adults aged 25 to 45 free of gastrointestinal and mental illness
    Effect: fecal Lactobacillus +235% vs control (p < .01); 25-30 billion CFU kefir cultures per serving
    Certainty: Microbiome shift only; no symptom outcome.
    Nutr Neurosci, 2023 · checked 2026-10-06 · we read the abstract
11. ev-kefg-11 · Observational data · non-randomized before-after pilot study, no control group · n = 20
    This pilot study shows that kefir has positive effects on the symptoms of constipation.
    
    Who: consecutive patients with functional constipation (Rome II), 10 normal and 10 slow transit
    Effect: stool frequency up (p<0.001), consistency improved (p=0.014), laxative use down (p=0.031), faster colonic transit in slow-transit group (p=0.013)
    Certainty: No control arm, so placebo and regression to the mean cannot be excluded; authors call for controlled trials.
    Turk J Gastroenterol, 2014 · checked 2026-10-06 · we read the abstract
12. ev-kefg-12 · Observational data · open-label phase I safety and feasibility study, escalating dose 2 fl oz (60 mL), 4.1 fl oz (120 mL), then 8.1 fl oz (240 mL) daily, NCT05416814 · n = 54
    Importantly, no cases of bacteremia, fungemia, or deaths were associated with kefir.
    
    Who: critically ill adults in the ICU with an intact gastrointestinal tract
    Effect: 0 bacteremia, fungemia or deaths linked to kefir; diarrhea in 2 patients on concurrent laxatives and tube feeds; 91% of 393 doses given
    Certainty: No control arm; median exposure only 3 days.
    BMC Med, 2024 · checked 2026-10-06 · we read the fulltext
13. ev-kefg-13 · Observational data · open-label phase I safety and feasibility study, Methods · n = 54
    (iii) dairy intolerance or milk allergies; (iv) an extremely poor prognosis where survival through the treatment period was unlikely; and (v) pregnancy.
    
    Who: exclusion criteria of the ICU kefir phase I study
    Effect: excluded: immunosuppression of at least 1 month (corticosteroids from 10 mg daily, TNF-alpha inhibitors, monoclonal antibodies), compromised gut integrity, dairy intolerance or milk allergy, pregnancy
    Certainty: An exclusion list, not a finding of harm; shows where live-culture safety is untested. Kefir is a milk product, so milk allergy applies.
    BMC Med, 2024 · checked 2026-10-06 · we read the fulltext
14. ev-kefg-14 · Position of an expert body · regulatory decision, EU Register on nutrition and health claims · n = 1 claim
    POL-HC-6400 Live yoghurt cultures Live cultures in yoghurt or fermented milk improve lactose digestion of the product in individuals who have difficulty digesting lactose Authorised
    
    Who: EU market, Article 13.1 claim for live yogurt cultures
    Effect: status Authorised; applies to lactose in the product itself; search for 'kefir' in the register returned nothing
    Certainty: Condition of use names yogurt starter organisms, which traditional kefir grains may lack.
    EU Register on nutrition and health claims, claim POL-HC-6400, snapshot 2026-09-21 · checked 2026-10-06 · we read the dataset
15. kef-c4-15 · Position of an expert body · regulation text, conditions of use of a permitted claim · n = 1 condition of use
    In order to bear the claim, yoghurt or fermented milk should contain at least 10⁸ Colony Forming Units live starter microorganisms (Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus) per gram.
    
    Who: EU market, Regulation (EU) No 432/2012 consolidated 2016, list of permitted health claims
    Effect: threshold 10^8 CFU per gram of the two named yogurt starter organisms
    Certainty: a legal threshold, not a study; traditional kefir grains contain other lactobacilli, lactococci and yeasts, so most kefirs do not meet the wording. Web quote checked by eye in two independent requests
    Regulation (EU) No 432/2012, consolidated text, EUR-Lex · checked 2026-09-23 · we read the section